A detailed history of Alliancebernstein L.P. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 52,894 shares of PCRX stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,894
Previous 52,830 0.12%
Holding current value
$1.03 Million
Previous $1.51 Million 47.32%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $28.46 $748 - $1,821
64 Added 0.12%
52,894 $796,000
Q1 2024

May 14, 2024

SELL
$27.7 - $35.48 $101,382 - $129,856
-3,660 Reduced 6.48%
52,830 $1.54 Million
Q4 2023

Feb 14, 2024

SELL
$26.32 - $34.31 $1,947 - $2,538
-74 Reduced 0.13%
56,490 $1.91 Million
Q3 2023

Nov 14, 2023

SELL
$30.68 - $40.09 $726,717 - $949,611
-23,687 Reduced 29.52%
56,564 $1.74 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $47.5 $887,974 - $1.17 Million
24,584 Added 44.16%
80,251 $3.22 Million
Q1 2023

May 15, 2023

SELL
$35.53 - $43.38 $3.79 Million - $4.63 Million
-106,769 Reduced 65.73%
55,667 $2.27 Million
Q4 2022

Feb 14, 2023

BUY
$38.19 - $57.45 $3.82 Million - $5.75 Million
100,049 Added 160.37%
162,436 $6.27 Million
Q3 2022

Nov 15, 2022

SELL
$51.24 - $58.89 $25,005 - $28,738
-488 Reduced 0.78%
62,387 $3.32 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $272,485 - $432,038
5,292 Added 9.19%
62,875 $3.67 Million
Q1 2022

May 13, 2022

SELL
$60.03 - $76.49 $1.01 Million - $1.29 Million
-16,859 Reduced 22.65%
57,583 $4.4 Million
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $4,221 - $5,474
88 Added 0.12%
74,442 $4.48 Million
Q3 2021

Nov 10, 2021

SELL
$54.64 - $61.3 $131,136 - $147,120
-2,400 Reduced 3.13%
74,354 $4.16 Million
Q2 2021

Jul 30, 2021

BUY
$59.18 - $69.99 $216,598 - $256,163
3,660 Added 5.01%
76,754 $4.66 Million
Q1 2021

May 06, 2021

BUY
$59.31 - $78.82 $40,330 - $53,597
680 Added 0.94%
73,094 $5.12 Million
Q4 2020

Feb 08, 2021

SELL
$50.47 - $66.26 $15,141 - $19,878
-300 Reduced 0.41%
72,414 $4.33 Million
Q3 2020

Nov 12, 2020

SELL
$51.97 - $63.0 $51,450 - $62,370
-990 Reduced 1.34%
72,714 $4.37 Million
Q2 2020

Aug 13, 2020

BUY
$30.8 - $52.47 $272,272 - $463,834
8,840 Added 13.63%
73,704 $3.87 Million
Q1 2020

May 14, 2020

BUY
$28.4 - $50.7 $1,420 - $2,535
50 Added 0.08%
64,864 $2.18 Million
Q4 2019

Feb 18, 2020

BUY
$36.31 - $46.83 $9,077 - $11,707
250 Added 0.39%
64,814 $2.94 Million
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $268,662 - $338,954
7,534 Added 13.21%
64,564 $2.46 Million
Q2 2018

Aug 13, 2018

SELL
$27.5 - $39.8 $44,495 - $64,396
-1,618 Reduced 2.76%
57,030 $1.83 Million
Q1 2018

May 14, 2018

BUY
$29.98 - $46.35 $12,531 - $19,374
418 Added 0.72%
58,648 $1.83 Million
Q3 2017

Nov 13, 2017

BUY
$35.7 - $39.5 $2.08 Million - $2.3 Million
58,230
58,230 $2.19 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.